SCHEMBL1379103

SCHEMBL1379103

Cc1cnc(NC(=O)c2cc(OCC(F)CF)cc(Oc3ncc(C(=O)N4CCC4)cc3Cl)c2)cn1

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.76
KCNH2 Q12809 10/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1426947 0.91 GCK (0.78) GCKKCNH2
SCHEMBL2654354 0.89 GCK (0.60) GCKKCNH2
SCHEMBL1378353 0.87 GCK (0.82) GCKKCNH2
SCHEMBL2656648 0.86 GCK (0.76) GCKKCNH2
SCHEMBL1427266 0.86 GCK (1.00) GCKKCNH2
SCHEMBL1426864 0.86 GCK (0.85) GCKKCNH2
SCHEMBL1376577 0.86 GCK (0.80) GCKKCNH2
SCHEMBL2656078 0.85 GCK (0.56) GCKKCNH2
SCHEMBL1376580 0.85 GCK (0.74) GCKKCNH2
SCHEMBL1427001 0.85 GCK (0.97) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4651714-B2 2011-03-16 JP claimed
EP-1902052-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2008-03-26 EP claimed
WO-2007007041-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2007-01-18 WO claimed